Omjjara 200 mg filmom obalené tablety

Code 5337E
MA number EU/1/23/1782/003
Product Form: tbl flm 30x200 mg (fľ.HDPE)
MA Status: E - Valid centralised marketing authorisation
Type of procedure: EU Orphan
Therapeutic Class: 44 - CYTOSTATICA
Shelf life: 36
Container: bottle HDPE
Route of admin.: Oral use
Prescription Status: Medicinal product subject to restricted medical prescription.
Legal basis: Article 8(3) application - new active substance
MA issued: 25.01.2024
Validity: 25.01.2029
SmPC + PL: European Medicines Agency's database
Safety feature Yes
Data update: 30.01.2024
eu-flag.png sk-flag.png